Category: Clinical Breakthroughs
-
Two Type 2 Diabetes Drugs Linked to Higher Risk of Heart Disease
Two drugs commonly prescribed to treat Type 2 diabetes carry a high risk of cardiovascular events such as heart attack, stroke, heart failure or amputation, according to a new Northwestern Medicine study.
-
Drug Regimen Improves Survival in Lymphoma
A drug called brentuximab vedotin combined with chemotherapy significantly improved overall survival for patients with a type of T-cell lymphoma, according to a clinical trial in The Lancet.
-
Resilience May Be Neurobiological
A new study aims to answer a resilience puzzle: Why second-hand experiences of neighborhood violence affect some youth, but not others.
-
Inflammatory Bowel Disease Linked to Prostate Cancer
Men with inflammatory bowel disease have four to five times higher risk of prostate cancer, according to a new 20-year study.
-
World’s Smallest Wearable Device Warns of UV Exposure, Enables Precision Phototherapy
The world’s smallest wearable device has been developed by Northwestern scientists, to measure exposure to light across multiple wavelengths.
-
High Blood Pressure Before Age 40 Linked to Heart Disease
Adults who develop high blood pressure before the age of 40 are at a significantly higher risk for cardiovascular events later in life, according to a Northwestern Medicine study.
-
Fighting Cancer, Becoming an Adult
Teens and young adults with cancer get support from a special oncology program. Read the story in Northwestern Medicine magazine.
-
An Exceptional Cancer Center
The Lurie Cancer Center solidifies its place among the country’s elite after extraordinary growth and a top rating from the National Cancer Institute. Read the story in Northwestern Medicine magazine.
-
Genetic Variants in Caffeine Perception
The more sensitive a person is to the bitter taste of caffeine, the more coffee they tend to drink, according to a new study.
-
Skin Sensor Could Improve Life for a Million Hydrocephalus Patients
A new wireless, Band-Aid-like sensor developed at Northwestern University could revolutionize the way patients manage hydrocephalus — a potentially life-threatening condition in which excess fluid builds up in the brain.
